anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
andMe · pitchdeck

23andMe | Investor Presentation Deck | 39 slides

39 pages · 3 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

23andMe | Investor Presentation Deck | 39 slides

andMe · 2024-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON
Narrative range 36 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 2 slides 100% 2/2 slides 100% 2/2 slides · 5 hits
— 0/2 slides
50% 1/2 slides 50% 1/2 slides 100% 2/2 slides 100% 2/2 slides Agitate (Make it worse) 3 slides 100% 3/3 slides 100% 3/3 slides · 16 hits
— 0/3 slides
100% 3/3 slides · 4 hits 66.7% 2/3 slides 100% 3/3 slides 100% 3/3 slides Solution (Provide relief) 31 slides 100% 31/31 slides 100% 31/31 slides · 138 hits
— 0/31 slides
32.3% 10/31 slides · 11 hits 35.5% 11/31 slides 100% 31/31 slides 25.8% 8/31 slides

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a vertical bracket to group three key pillars under the umbrella of 'GENETICS'.present_solution
Open slide detailLoop · Logic Chain
04
The slide uses a circular hub-and-spoke diagram centered on 'Patients' to connect three core pillars: Need, Speed, and Power.inspire_vision
Open slide detailBeat · Problem (Identify pain)Loop · Logic Chain
05
transition
Open slide detailBeat · Problem (Identify pain)Loop · Logic Chain
06
The slide highlights the competitive advantage of scale and recontactability, supported by a callout on consent rates and a metric on drug success probability.show_traction
Open slide detailBeat · Agitate (Make it worse)Loop · Logic Chain
07
The slide highlights the scale of 23andMe's proprietary data by listing specific case counts for various oncology and immune conditions.analyze_data
Open slide detailBeat · Agitate (Make it worse)Loop · Logic Chain
08
The slide uses a '2x-3x' metric to justify the value of genetic support in drug discovery, citing Nelson et al. (2015) and King et al. (2019).compare_peers
Open slide detailBeat · Agitate (Make it worse)Loop · Logic Chain
09
Includes a Manhattan plot visualization and a zoomed-in regional association plot.establish_context
Open slide detailBeat · Solution (Provide relief)Loop · Logic Chain
10
The chart is a dot plot showing odds ratios for various phenotypes related to TSLP.analyze_data
Open slide detailBeat · Solution (Provide relief)Loop · Logic Chain
11
The slide demonstrates how 23andMe's genetic data can rescue or refine clinical trial results by identifying biomarkers that stratify patient response.show_traction
Open slide detailBeat · Solution (Provide relief)Loop · Logic Chain
12
The slide uses a process flow diagram to explain the 'POWER' methodology.present_solution
Open slide detailBeat · Solution (Provide relief)Loop · Logic Chain
13
inspire_vision
Open slide detailBeat · Solution (Provide relief)
14
The slide uses a process flow to demonstrate the predictive power of their genomic platform.present_solution
Open slide detailBeat · Solution (Provide relief)
15
FxG likely stands for Functional Genomics. The slide uses a process flow diagram to illustrate the R&D pipeline.present_solution
Open slide detailBeat · Solution (Provide relief)
16
transition
Open slide detailBeat · Solution (Provide relief)
17
present_solution
Open slide detailBeat · Solution (Provide relief)
18
The slide uses a process flow to illustrate the speed of development, supported by heatmaps and a bar chart showing adverse event profiles.show_traction
Open slide detailBeat · Solution (Provide relief)
19
transition
Open slide detailBeat · Solution (Provide relief)
20
other
Open slide detailBeat · Solution (Provide relief)
21
The slide uses a timeline-based pipeline visualization common in biotech investor decks.plan_implementation
Open slide detailBeat · Solution (Provide relief)
22
The slide uses a gradient background and serves as a transition to a specific clinical asset.transition
Open slide detailBeat · Solution (Provide relief)
23
Includes survival curves, immunohistochemistry images, genetic association data, and clinical trial data for atopic dermatitis.frame_problem
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
24
The slide uses a three-column layout to present pharmacology, mechanism of action (diagram), and clinical development status.present_solution
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
25
The chart uses a swimmer plot format to visualize patient-level treatment duration, dose escalation, and response status.show_traction
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
26
Includes before-and-after CT scan imagery for two lesion types.show_traction
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
27
The slide uses a Gantt-style visualization to map clinical trial milestones (First Efficacy Assessment, 6-mo PFS/OS, 12-mo PFS/OS) against calendar quarters froplan_implementation
Open slide detailBeat · Solution (Provide relief)
28
The chart demonstrates superior efficacy of 23ME-00610 over anti-PD1 in stimulating IFNy across multiple cancer types.present_solution
Open slide detailBeat · Solution (Provide relief)
29
The chart shows statistical significance (p<0.01 and p<0.0001) for the combination therapy.present_solution
Open slide detailBeat · Solution (Provide relief)
30
state_next_steps
Open slide detailBeat · Solution (Provide relief)
31
transition
Open slide detailBeat · Solution (Provide relief)
32
The slide uses a combination of a data table, a biological mechanism diagram, and a summary of clinical validation to support the therapeutic thesis.present_solution
Open slide detailBeat · Solution (Provide relief)
33
The slide uses a combination of a biological process diagram and a line chart showing tumor cell reduction over time.present_solution
Open slide detailBeat · Solution (Provide relief)
34
transition
Open slide detailBeat · Solution (Provide relief)
35
The slide uses a process-flow diagram at the bottom to map team expertise to the drug discovery pipeline.other
Open slide detailBeat · Solution (Provide relief)
36
Uses a Venn-like diagram to show genetic overlap between asthma and other conditions (COPD, eczema, neuro-inflammation, urticaria) to drive specific R&D strategpresent_solution
Open slide detailBeat · Solution (Provide relief)
37
Uses a bell curve distribution to illustrate the selection strategy for cases and controls.present_framework
Open slide detailBeat · Solution (Provide relief)
38
The slide uses a table to categorize biological targets by cell type and associated disease indications.present_framework
Open slide detailBeat · Solution (Provide relief)
39
front_matter
Open slide detailBeat · Solution (Provide relief)